{"id":2394,"date":"2020-10-13T08:38:02","date_gmt":"2020-10-13T06:38:02","guid":{"rendered":"https:\/\/cendoc.h12o.es\/blog\/?p=2394"},"modified":"2020-10-13T08:38:02","modified_gmt":"2020-10-13T06:38:02","slug":"neoplasias-hematologicas-covid-19-y-h12o","status":"publish","type":"post","link":"https:\/\/cendoc.h12o.es\/blog\/2020\/10\/13\/neoplasias-hematologicas-covid-19-y-h12o\/","title":{"rendered":"Neoplasias hematol\u00f3gicas, COVID-19 y H12O"},"content":{"rendered":"<p>El Servicio de Hematolog\u00eda del Hospital 12 de Octubre (Joaqu\u00edn Mart\u00ednez L\u00f3pez y Rodrigo Gil Manso) y el <img loading=\"lazy\" decoding=\"async\" class=\" wp-image-3871 alignright\" src=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg\" alt=\"logo12\" width=\"232\" height=\"158\" data-attachment-id=\"3871\" data-permalink=\"https:\/\/coronavirusbiblioh12o.wordpress.com\/2020\/05\/06\/7-mas-del-h12o\/logo12\/\" data-orig-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg\" data-orig-size=\"275,183\" data-comments-opened=\"1\" data-image-meta=\"{&quot;aperture&quot;:&quot;0&quot;,&quot;credit&quot;:&quot;&quot;,&quot;camera&quot;:&quot;&quot;,&quot;caption&quot;:&quot;&quot;,&quot;created_timestamp&quot;:&quot;0&quot;,&quot;copyright&quot;:&quot;&quot;,&quot;focal_length&quot;:&quot;0&quot;,&quot;iso&quot;:&quot;0&quot;,&quot;shutter_speed&quot;:&quot;0&quot;,&quot;title&quot;:&quot;&quot;,&quot;orientation&quot;:&quot;0&quot;}\" data-image-title=\"logo12\" data-image-description=\"\" data-medium-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=275\" data-large-file=\"https:\/\/coronavirusbiblioh12o.files.wordpress.com\/2020\/05\/logo12.jpg?w=275\" \/>Instituto de Investigaci\u00f3n i+12 (Javier de la Cruz) colaboran en un art\u00edculo publicado en el <em>Journal of Hematology &amp; Oncology<\/em>: \u201c<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7542567\/pdf\/13045_2020_Article_970.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study<\/a>\u201d.<\/p>\n<p>Los pacientes con COVID-19 y c\u00e1ncer tienen mayor riego de gravedad cl\u00ednica y mortalidad que aquellos pacientes con COVID-19 que no tienen c\u00e1ncer; adem\u00e1s los pacientes con tumores hematol\u00f3gicos tienen niveles m\u00e1s altos de inmunosupresi\u00f3n que los que padecen tumores s\u00f3lidos. Los datos sobre pacientes hematol\u00f3gicos con COVIUD-19 son muy limitados, de ah\u00ed el estudio que ha posibilitado esta publicaci\u00f3n. Se recogen informaci\u00f3n cl\u00ednica de 697 pacientes con COVID-19 y neoplasias hematol\u00f3gicas de 27 centros sanitarios de Madrid, entre febrero y mayo de 2020. En un 62% de ellos la COVID-19 se desarroll\u00f3 de forma grave. Una mayor mortalidad se asoci\u00f3 con una edad superior a 60 a\u00f1os, m\u00e1s de 2 comorbilidades, leucemia mieloide aguda y tratamiento con anticuerpos monoclonales. En cambio, neoplasias mieloproliferativas y el tratamiento con agentes hipometilantes se asociaron con una menor mortalidad. Estas conclusiones requieren m\u00e1s estudios y tiempo para ser validadas.<\/p>\n<p><em>Equipo Biblioteca H12O<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El Servicio de Hematolog\u00eda del Hospital 12 de Octubre (Joaqu\u00edn Mart\u00ednez L\u00f3pez y Rodrigo Gil Manso) y el Instituto de Investigaci\u00f3n i+12 (Javier de la Cruz) colaboran en un art\u00edculo publicado en el Journal of Hematology &amp; Oncology: \u201cImpact of hematologic malignancy and type of cancer therapy on COVID-19 severity \u2026<\/p>\n<p class=\"continue-reading-button\"> <a class=\"continue-reading-link\" href=\"https:\/\/cendoc.h12o.es\/blog\/2020\/10\/13\/neoplasias-hematologicas-covid-19-y-h12o\/\">Continuar leyendo<i class=\"crycon-right-dir\"><\/i><\/a><\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","enabled":false},"version":2}},"categories":[4,64,46],"tags":[],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p3G9TJ-CC","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/2394"}],"collection":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/comments?post=2394"}],"version-history":[{"count":1,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/2394\/revisions"}],"predecessor-version":[{"id":2395,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/posts\/2394\/revisions\/2395"}],"wp:attachment":[{"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/media?parent=2394"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/categories?post=2394"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cendoc.h12o.es\/blog\/wp-json\/wp\/v2\/tags?post=2394"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}